Q32 Bio Inc.
Nasdaq QTTB · Waltham, MA
Works in Dermatology · Genetic & rare · Immunology
Q32 Bio Inc. is a clinical trial sponsor based in Waltham, MA, listed as Nasdaq QTTB. It has 2 active clinical trials with 177 planned participants, in Dermatology, Genetic & rare and Immunology. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq QTTB
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Q32 Bio Inc
Q32 Bio Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 177 planned participants, in Dermatology, Genetic & rare, Immunology. Since 2021 it has completed 1 trial and stopped 0 early.
Q32 Bio Inc is based in Waltham, MA and is listed as Nasdaq QTTB. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Q32 Bio Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-05-08.
Approve Suite is not affiliated with Q32 Bio Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.